Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation
about
Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosisWhole-genome sequence-based analysis of high-density lipoprotein cholesterolConformational and aggregation properties of the 1-93 fragment of apolipoprotein A-I.Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations.ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis.Impact of self-association on function of apolipoprotein A-IAssociation of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitusA Cross-Sectional Study Demonstrating Increased Serum Amyloid A Related Inflammation in High-Density Lipoproteins from Subjects with Type 1 Diabetes Mellitus and How this Association Was Augmented by Poor Glycaemic Control.Glycation of apoprotein A-I is associated with coronary artery plaque progression in type 2 diabetic patients.Tweaking the cholesterol efflux capacity of reconstituted HDL.Sequence-specific apolipoprotein A-I effects on lecithin:cholesterol acyltransferase activity.Transfer of C-terminal residues of human apolipoprotein A-I to insect apolipophorin III creates a two-domain chimeric protein with enhanced lipid binding activity.
P2860
Q28116206-9EFB9AF2-7BDD-4DD2-A9CA-8951F2D5ACF8Q28659476-D8C9E1E1-A4B9-416C-A57D-6D9E3C2A7EDCQ34559652-7B422EE9-B4AF-4C39-9DB6-EBAC1ADCA1ACQ34988258-1DB4952D-0574-4527-B612-2083C0C88B30Q35098335-42565CFE-4B4A-468E-AB49-C25769F9CFE6Q35371440-27E56653-BAC6-448C-8544-A0CB2C2E62ECQ35610045-F3B5D555-7752-4AE7-9B6A-1B4F9D54D292Q36236202-8BE86122-0451-4FDF-A5BA-E9AC283811BAQ36782743-AF03DB49-CDA5-40D7-B8B4-FF14946F3719Q39616002-5D9671C1-72BD-4AAC-BCFC-7D1E026A9D39Q44923253-CCF2975D-D95B-42F2-A371-3E70A9793342Q45968902-0C302142-6EE6-4374-90E7-DBB145837A5B
P2860
Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Novel N-terminal mutation of h ...... on and impairs LCAT activation
@ast
Novel N-terminal mutation of h ...... on and impairs LCAT activation
@en
Novel N-terminal mutation of h ...... on and impairs LCAT activation
@nl
type
label
Novel N-terminal mutation of h ...... on and impairs LCAT activation
@ast
Novel N-terminal mutation of h ...... on and impairs LCAT activation
@en
Novel N-terminal mutation of h ...... on and impairs LCAT activation
@nl
prefLabel
Novel N-terminal mutation of h ...... on and impairs LCAT activation
@ast
Novel N-terminal mutation of h ...... on and impairs LCAT activation
@en
Novel N-terminal mutation of h ...... on and impairs LCAT activation
@nl
P2093
P2860
P356
P1476
Novel N-terminal mutation of h ...... on and impairs LCAT activation
@en
P2093
Anouar Hafiane
Arti B Patel
Cyril M Kay
Emmanuel Guigard
Leon C-P Wan
Paul M M Weers
Robert S Kiss
Ruth McPherson
Yves L Marcel
P2860
P356
10.1194/JLR.M007500
P577
2010-09-30T00:00:00Z